Third Rock-backed autoimmune biotech turns off the lights
A Third Rock Ventures biotech created to make new medicines for autoimmune and inflammatory diseases has shuttered, Endpoints News has learned.
Rheos Medicines changed its registered office address and registered agent last month to that of a Foxborough, MA accounting firm that specializes in bankruptcies, per January documents. A Third Rock spokesperson confirmed to Endpoints that Rheos wound down “late last year.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.